CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance-Reference-Cited by-同舟云学术

CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance

Published:2005-03 Issue:1 Volume:333 Page:1-9
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Molesworth-Kenyon Sara,Mates Aaron,Yin Rong,Strieter Robert,Oakes John,Lausch Robert

Publisher

Elsevier BV

Subject

Virology

Reference43 articles.

1. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome;Belperio;J. Immunol.,2002

2. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s;Bonecchi;J. Exp. Med.,1998

3. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice;Bouley;J. Immunol.,1995

4. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection;Carr;J. Virol.,2003

5. IFNgamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking;Dufour;J. Immunol.,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure;iScience;2022-12

2. Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration;Frontiers in Immunology;2021-11-15

3. IL-1α Modulates IFN-γ-Induced Production of CXCL9/MIG during Herpes Simplex Virus Type-1 Corneal Infection;Current Eye Research;2020-09-15

4. CCR6-Positive γδ T Cells Provide Protection Against Intracorneal HSV-1 Infection;Investigative Opthalmology & Visual Science;2019-09-23

5. Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation;Frontiers in Immunology;2017-11-23